Bank Of America Corp Enochian Biosciences Inc Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Bank Of America Corp holds 88,366 shares of ENOB stock, worth $406,483. This represents 0.0% of its overall portfolio holdings.

Number of Shares

88,366

Previous 26,335 235.55%

Holding current value

$406,483

Previous $121,000 235.54%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	N/A	62,031 Added 235.55%	88,366 $406,000
Q2 2024 Aug 14, 2024	BUY	N/A	24,555 Added 1379.49%	26,335 $121,000
Q1 2024 May 15, 2024	SELL	N/A	-44,482 Reduced 96.15%	1,780 $8,000
Q4 2023 Feb 14, 2024	BUY	$4.3 - $4.7 $191,268 - $209,060	44,481 Added 2497.53%	46,262 $212,000
Q2 2023 Aug 14, 2023	SELL	$0.4 - $1.3 $10,884 - $35,375	-27,212 Reduced 93.86%	1,781 $1,000
Q1 2023 May 12, 2023	BUY	$0.91 - $1.31 $4,858 - $6,994	5,339 Added 22.57%	28,993 $26,000
Q4 2022 Feb 10, 2023	SELL	$1.03 - $2.13 $4,133 - $8,547	-4,013 Reduced 14.5%	23,654 $24,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $2.86 $41,367 - $69,595	24,334 Added 730.09%	27,667 $50,000
Q2 2022 Aug 12, 2022	SELL	$1.93 - $8.73 $30,627 - $138,536	-15,869 Reduced 82.64%	3,333 $6,000
Q1 2022 May 16, 2022	BUY	$4.42 - $9.0 $18,245 - $37,152	4,128 Added 27.38%	19,202 $158,000
Q4 2021 Feb 08, 2022	BUY	$6.71 - $12.55 $101,146 - $189,178	15,074 New	15,074 $110,000
Q3 2021 Nov 15, 2021	SELL	$4.56 - $7.88 $12,321 - $21,291	-2,702 Closed	0 $0
Q2 2021 Sep 13, 2021	BUY	$2.94 - $6.79 $7,943 - $18,346	2,702 New	2,702 $13,000

Others Institutions Holding ENOB

# of Institutions

Shares Held

14.7M

Call Options Held

24K

Put Options Held

19.1K

View Full List

About Enochian Biosciences Inc

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

More about ENOB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Enochian Biosciences Inc Transaction History